Skip to content
Search

Latest Stories

Issa brothers may join race to buy pharmacy chain Boots

Issa brothers may join race to buy pharmacy chain Boots

BLACKBURN’S Issa brothers are mulling over joining the race to acquire pharmacy chain Boots as the billionaire owner of Asda and EG Group seek to diversify their retail portfolio further, media reports said.

Boots’ parent Walgreens Boots Alliance has begun a strategic review of the Nottingham-based chemist chain which has about 2200 stores in the UK.

Private investment firms Bain Capital and CVC Capital Partners are also mulling a joint bid for Boots which could be worth £10 billion, The Telegraph said.

Its auction, which is expected in the coming weeks, is likely to attract large retainers.

However, the Issas’ debt-driven expansion plans may face hurdles as borrowing costs are edging higher with central banks seeking to contain inflation.

The siblings - Mohsin and Zuber - who began their retail business with just one fuel station two decades ago but went on to expand their empire beyond the UK, took over Asda from Walmart in a £6.8 bn deal.

They borrowed £3.5bn to finance the transaction and their debt mounted by a further £500 million after their plans to sell Asda’s petrol stations to EG Group fell through.

The Issas did not react to media reports about their interest in Boots.

Founded as a herbal medicine store in Nottingham in 1849, Boots went through a series of acquisitions over the years.

In 2014, it became a subsidiary of Walgreens Boots Alliance after Walgreens bought a controlling stake in Alliance Boots.

It was reported last year that the Issa brothers were weighing the option of merging Asda with EG Group and that they were planning to offload their Australian fuel station chain.

More For You

Elon Musk and Sam Altman
Musk vs Altman: $134bn battle over OpenAI’s future heads to court
Getty Images / Edited in Canva

Musk vs OpenAI: Is the $134bn battle driven by rivalry as company claims?

  • Elon Musk accuses OpenAI of abandoning its non-profit mission
  • Trial could shape control, structure and future of one of AI’s biggest players
  • Top tech figures, including Microsoft’s CEO, expected to testify

A long-running dispute between Elon Musk and Sam Altman has now reached a courtroom in California, setting the stage for one of the most closely watched trials in the tech world. The case, centred on the direction and control of OpenAI, begins with jury selection in Oakland and is expected to run for up to three weeks.

At its core, the lawsuit questions whether OpenAI drifted away from its original purpose. Musk claims the company he co-founded in 2015 as a non-profit has shifted into a profit-driven enterprise, breaching its founding principles. He has named Altman, OpenAI president Greg Brockman and major partner Microsoft in the case, accusing them of breach of contract and unjust enrichment.

Keep ReadingShow less